Skip to main content
Loading

Optimizing structure-based drug design with machine learning

26 Sep 2024
Lead Generation & Optimization
  • How is machine learning accelerating the identification and optimization of lead compounds in current structure-based drug design projects?
  • Considering the rapid evolution of AI, what emerging machine learning techniques hold the greatest promise for structurally informed lead optimization in the near future?
  • What are your greatest practical challenges in developing and deploying structure-based drug design models?
  • Prediction of three-dimensional structures is becoming more tenable across a variety of molecule types with tools such as AlphaFold 3; what are the main challenges and opportunities for incorporating 3D structures into structure-based drug design?
Industry Expert
Evan Mccartney-Melstad, Director of Bioinformatics - Nutcracker Therapeutics